See the chaos!
Tasty* Flea and Tick Protection for Cats
Cats can be picky when it comes to flea and tick treatment. That’s why Credelio Cat was specifically designed to meet cats’ flea and tick protection needs in a tiny tablet that is easy* for pet owners to administer. It is the first and only oral flea and tick product for cats, formulated especially for your feline patients.
99.5% of Cats (and Clinic Staff) Can’t be Wrong!*
We know it’s hard to believe that many cats
agreed to anything. So, we took our stats on the road and used donuts to test the study results for ourselves.
Do Cats Really Take It?
Actual Footage of Actual Cats!
No tricks Needed
Because of its unique smell and taste, most cats will take the tablet on its own
With Food
Add the tablet in a meal of their wet or dry food
Out of The Hand
You can offer the tablet from the tips of your fingers, avoiding the palm of your hand
With a Treat
Whether it’s a lickable or some yogurt, give the tablet alongside their favorite treat
Designed Just for Cats!
Cats have a limited amount of taste buds and rely heavily on smell when deciding what to eat.1
Testing took this into account and determined that vanilla and yeast were the combo cats wanted.2
Vanilla provides an attractive aroma that cats find appealing, yeast helps with palatability providing a savory flavor.
Cats Actually Eat It! Never had it returned for refusal to take in food or handfeed. Excellent Product, highly recommend.
— Credentialed Technician, Florida
Administration Details
For full efficacy against ticks and fleas, instruct pet owners to always give their cat Credelio Cat with food or within 30 minutes of a meal. The presence of food ensures that peak blood levels and exposures are achieved, which is necessary for initial and ongoing efficacy.
Credelio Cat should be administered once a month, every month, to cats and kittens 8 weeks of age or older and 2.0 lbs or greater to provide year-round protection against fleas. Credelio Cat is indicated for the treatment and control of black-legged ticks for one month in cats and kittens at 6 months of age or older and 2.0 lbs or greater.
Credelio Cat is a simple and tasty* way to protect cats against ticks and fleas
Cats are complex creatures, and as a result, owners can find medicating cats at home daunting. However, by considering the natural behaviors of cats, we developed a tiny, tasty* tablet that offers an alternative to traditional topical flea and tick treatments.
Easy-to-give* option for pet owners who dislike or struggle to apply topical treatments
Small size, pleasant aroma and high palatability make administration easy*
In a U.S. field study, 99.5% of cat owners successfully administered
Credelio Cat*
Credelio Cat for the Win! Lots of pet owners have trouble with applying topical flea medications. We love Credelio Cat because of the flavor and ease of administering!
— Inventory Manager, Washington
Flea efficacy
Credelio Cat kills fleas before they can lay eggs. It maintains fast-acting and sustained flea efficacy throughout the entire month — no drop-off.3,4
Credelio Cat is approved for the treatment and prevention of flea infestations in cats 8 weeks and older weighing 2.0 pounds or more.
Flea control should be considered one of the first steps for any cat that presents with:
- Hair loss from excessive grooming or rubbing
- Miliary dermatitis
- Eosinophilic granuloma complex
- Itching and rubbing around the head and neck
Improved Flea Allergy Dermatitis (FAD) Signs Due to Quick Flea-Kill
Tick efficacy
Effective, sustained Ixodes scapularis tick kill
I. scapularis, also known as the black-legged or deer tick, is the most common tick infesting cats. It is most often found on the head, neck and ears and can be a threat year-round.6
Credelio Cat kills 97-100% of I. scapularis ticks at 72 hours after administration or infestation throughout the month.7
Credelio Cat is approved for the treatment and control of I. scapularis in cats 6 months and older weighing 2.0 pounds or more.
Credelio Cat Product Information
Kills adult fleas and is indicated for the treatment and prevention of flea infestations for one month in cats and kittens 8 weeks of age and older and weighing 2.0 lbs or greater.
Is also indicated for the treatment and control of black-legged tick infestations in cats and kittens 6 months or age and older and weighing 2.0 lbs or greater.
Ticks and fleas
Cats and kittens
Monthly chewable
lotilaner
1 month
6-, 3- and 1-count chewable tablets
Credelio Cat Dosing Table
Credelio Cat is available in 2 different weight bands, enabling you to offer pet owners convenient and easy administration.
| Cat Weight - Lotilaner / tablet |
| 2.0 - 4.0 lbs - 12 mg |
| 4.1 - 17.0 lbs - 48 mg |
| Greater than 17.0 lbs - - |
| Cat Weight - Tablet administered |
| 2.0 - 4.0 lbs - one |
| 4.1 - 17.0 lbs - one |
| Greater than 17.0 lbs - Administer the appropriate combination |
| Cat Weight | 2.0 - 4.0 lbs | 4.1 - 17.0 lbs | Greater than 17.0 lbs |
|---|---|---|---|
| Lotilaner / tablet | 12 mg | 48 mg | - |
| Tablet administered | one | one | Administer the appropriate combination |
Not actual size.
Acts fast against fleas
1: Starts killing fleas within 6 hours
2: Kills more than 98% of fleas by 12 hours
3: Kills 100% of fleas by 24 hours
Treats and controls ticks
Credelio Cat effectively kills the black-legged tick (𝘐𝘹𝘰𝘥𝘦𝘴 𝘴𝘤𝘢𝘱𝘶𝘭𝘢𝘳𝘪𝘴), the most common tick infesting cats 6 months or older.⁶
Designed specifically for cats, with an appealing smell and flavor
In a U.S. field study, 99.5% of cat owners successfully administered Credelio Cat to a diverse range of cats.*
Credelio® CAT (lotilaner) Resources
Credelio® CAT (lotilaner) FAQs
Pet Protection with E’s
Find the right Credelio family product for your pets
7 in 1 parasite coverage§ for dogs
Only Credelio Quattro™/Credelio Quattro-CA1 covers more* parasite types than other isoxazoline endectocides, targeting 7 types of parasites§ in one flavored chewable.
*Based on label comparison of the number of parasite types covered in an isoxazoline endectocide
§Credelio Quattro protects dogs against ticks, fleas, heartworm disease, roundworms, hookworms, and tapeworms. Credelio Quattro-CA1 is conditionally approved for the treatment of New World screwworm larvae infestations in dogs pending a full demonstration of effectiveness.
Fast-acting tick and flea protection for dogs
Don't give ticks and fleas a fighting chance. Credelio delivers rapid, consistent tick and flea protection that lasts all month long in a small, tasty chewable.
The first and only oral flea and tick protection for cats
Credelio Cat was specifically developed with feline preferences in mind, including a unique vanilla-yeast aroma designed to support ease of administration, which resulted in a 99.5% administration rate by cat owners in a U.S. field study*
*U.S. field study (648 doses, 225 cats): 21.1% from hand, 25.8% taken with food, 52.6% when placed in mouth, 0.5% not administered.
Credelio CAT
Emergency Use Authorization for Credelio CAT (lotilaner) for New World Screwworm (NWS)
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the approved product Credelio CAT (lotilaner) for the treatment of infestations caused by NWS (Cochliomyia hominivorax) larvae (myiasis) in cats and kittens. Credelio CAT is not approved for this use.
Credelio CAT is approved for other uses.
For additional information on the EUA, please refer to the Credelio CAT NWS Fact Sheet.
Limitations of Authorized Use
Credelio CAT (lotilaner) is authorized for this use only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of Credelio CAT (lotilaner) under section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Approved Indications
Credelio® CAT kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) for one month in cats and kittens 8 weeks of age and older and weighing 2.0 lbs or greater.
Credelio® CAT is also indicated for treatment and control of Ixodes scapularis (black-legged tick) infestations for one month in cats and kittens 6 months of age and older and weighing 2.0 lbs or greater.
Important Safety Information
Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. The safety of Credelio® CAT has not been established in breeding, pregnant and lactating cats. The effectiveness of Credelio® CAT against Ixodes scapularis in kittens less than 6 months of age has not been evaluated. The most frequently reported adverse reactions are weight loss, tachypnea and vomiting. For full prescribing information see the Credelio® CAT package insert.
Credelio
Emergency Use Authorization for Credelio (lotilaner) for New World screwworm (NWS)
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the approved product Credelio (lotilaner) for the treatment of infestations caused by NWS (Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies. However, Credelio is not approved for this use.
Credelio is approved for other uses.
For additional information on the EUA, please refer to the Credelio NWS Fact Sheet.
Limitations of Authorized Use
Credelio (lotilaner) is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of Credelio (lotilaner) under section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Approved Indications
Credelio kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick)] and Haemaphysalis longicornis (longhorned tick)] for one month in dogs and puppies 8 weeks of age and older and weighing 4.4 pounds or greater. Credelio is indicated for the prevention of Borrelia burgdorferi infections (also known as Lyme disease) as a direct result of killing Ixodes scapularis vector ticks.
Important Safety Information (ISI)
Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving this class of drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of Credelio® in breeding, pregnant or lactating dogs has not been evaluated. The most frequently reported adverse reactions are weight loss, elevated blood urea nitrogen, polyuria, and diarrhea. For full prescribing information see the Credelio® package insert.
Credelio Quattro/Credelio Quattro-CA1
Indications: Credelio Quattro is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina), hookworm (fourth stage larvae, immature adult, and adult Ancylostoma caninum and adult Uncinaria stenocephala), and tapeworm (Dipylidium caninum, Taenia pisiformis, and Echinococcus granulosus) infections. Credelio Quattro kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), and Haemaphysalis longicornis (longhorned tick)] for one month in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater. Credelio Quattro is indicated for the prevention of Borrelia burgdorferi infections (also known as Lyme disease) as a direct result of killing Ixodes scapularis vector ticks.
Credelio Quattro-CA1 is conditionally approved for the treatment of infestations caused by New World screwworm (NWS; Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater.
Important Safety Information: Lotilaner, an ingredient in Credelio Quattro/Credelio Quattro-CA1, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, ataxia, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro/Credelio Quattro-CA1 administration as it is not effective against adult D. immitis. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.
Credelio Quattro-CA1 is conditionally approved by the FDA pending a full demonstration of effectiveness under application number 141-619. Treatment of NWS myiasis includes removal of the larvae, lesion cleaning and surgical debridement. Implement appropriate wound care and pain management.
For full prescribing information, see the Credelio Quattro/Credelio Quattro-CA1 package insert.
